Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Plasma cell 1

Conditions

Waldenstrom Macroglobulinemia 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 63fludarabine phosphate 57Peripheral Blood Stem Cell Transplantation 52Mycophenolic Acid 42Cyclosporine 35Whole-Body Irradiation 34Tacrolimus 32Busulfan 30Antilymphocyte Serum 30Filgrastim 28Radiotherapy 25Methotrexate 23Methylprednisolone 17Melphalan 17Etoposide 15Cord Blood Stem Cell Transplantation 14Therapeutics 10Flow Cytometry 10fludarabine 9Sirolimus 8Psychiatric Rehabilitation 8Granulocyte Colony-Stimulating Factor 8Cytarabine 8Polymerase Chain Reaction 7sargramostim 6Rituximab 6Alemtuzumab 6Thiotepa 5Prednisone 5Carmustine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × Bleomycin × Plasma cell × Clear all
NCT00002657 2013-01-24

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

SWOG Cancer Research Network

Phase 2 Completed
20 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡